Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gain Therapeutics (GANX) Exchange Rate Effect (2020 - 2025)

Gain Therapeutics has reported Exchange Rate Effect over the past 6 years, most recently at $97760.0 for Q4 2025.

  • Quarterly results put Exchange Rate Effect at $97760.0 for Q4 2025, up 120.34% from a year ago — trailing twelve months through Dec 2025 was $474032.0 (up 189.92% YoY), and the annual figure for FY2025 was $474032.0, up 189.92%.
  • Exchange Rate Effect for Q4 2025 was $97760.0 at Gain Therapeutics, up from $6667.0 in the prior quarter.
  • Over the last five years, Exchange Rate Effect for GANX hit a ceiling of $483249.0 in Q4 2023 and a floor of -$480592.0 in Q4 2024.
  • Median Exchange Rate Effect over the past 5 years was $28087.0 (2021), compared with a mean of $25612.4.
  • Biggest five-year swings in Exchange Rate Effect: plummeted 1251.69% in 2024 and later soared 1881.94% in 2025.
  • Gain Therapeutics' Exchange Rate Effect stood at $64508.0 in 2021, then skyrocketed by 250.42% to $226051.0 in 2022, then skyrocketed by 113.78% to $483249.0 in 2023, then crashed by 199.45% to -$480592.0 in 2024, then surged by 120.34% to $97760.0 in 2025.
  • The last three reported values for Exchange Rate Effect were $97760.0 (Q4 2025), $6667.0 (Q3 2025), and $260070.0 (Q2 2025) per Business Quant data.